Clinically, NNMT expression is significantly upregulated in adipose tissue of patients with type 2 diabetes mellitus and insulin resistance, supporting NNMT inhibition as a potential therapeutic strategy for metabolic risk factors associated with CVD [22]. Here, NNMT is linked to diabetes mellitus.